Is Vijaya Diagnostic Centre (VIJAYA) overvalued or fairly valued?

MarketChacha shows Vijaya Diagnostic Centre's valuation in context — a forward P/E of about 49.9, a price-to-book of about 14.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Vijaya Diagnostic Centre's revenue?

Vijaya Diagnostic Centre reported revenue of ₹814 Cr for FY2026, with net profit of ₹173 Cr, per official filings.

What is the share price of Vijaya Diagnostic Centre (VIJAYA)?

Vijaya Diagnostic Centre last traded at ₹1,313.10 (-1.6% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Vijaya Diagnostic Centre

VIJAYA · NSE · Healthcare · India

₹1,313.10-1.6%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 9:59 AM

Snapshot

TickerVIJAYA

ExchangeNSE

SectorHealthcare

IndustryDiagnostics & Research

CountryIndia

HeadquartersHyderabad, India

Market cap₹13,511 Cr

P/B14.1

Volume1.65L

Websitewww.vijayadiagnostic.com

Filings tracked0

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters52.5%
Institutions39.9%
Public & other7.7%

54 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend18.4% → 21.2%

Margin has expanded by about 2.8 points — the business is getting more profitable.

Growth qualityrev 21% · PAT 27%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹1,154 Cr · EPS 26.34

Est. earnings growth +26.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹848.0052-wk range₹1,440.00

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹13,511 Cr

Day change

-1.6%

Fwd P/E

49.9

P/B

14.1

Div yield

0.15%

Beta

0.34

Revenue (FY2026)

₹814 Cr

Net margin

21.2%

Revenue CAGR (3y)

+21.0%

Profit CAGR (3y)

+26.9%

Net profit (FY2026)

₹173 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about VIJAYA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹814 Cr	₹173 Cr	21.2%
FY2025	₹681 Cr	₹143 Cr	21.0%
FY2024	₹548 Cr	₹119 Cr	21.7%
FY2023	₹459 Cr	₹85 Cr	18.4%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹219 Cr	₹48 Cr	21.8%
2025Q4	₹205 Cr	₹43 Cr	21.0%
2025Q3	₹202 Cr	₹43 Cr	21.5%
2025Q2	₹188 Cr	₹38 Cr	20.4%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.